581. CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea.
作者: R Doug McEvoy.;Nick A Antic.;Emma Heeley.;Yuanming Luo.;Qiong Ou.;Xilong Zhang.;Olga Mediano.;Rui Chen.;Luciano F Drager.;Zhihong Liu.;Guofang Chen.;Baoliang Du.;Nigel McArdle.;Sutapa Mukherjee.;Manjari Tripathi.;Laurent Billot.;Qiang Li.;Geraldo Lorenzi-Filho.;Ferran Barbe.;Susan Redline.;Jiguang Wang.;Hisatomi Arima.;Bruce Neal.;David P White.;Ron R Grunstein.;Nanshan Zhong.;Craig S Anderson.; .
来源: N Engl J Med. 2016年375卷10期919-31页
Obstructive sleep apnea is associated with an increased risk of cardiovascular events; whether treatment with continuous positive airway pressure (CPAP) prevents major cardiovascular events is uncertain.
582. Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure.
作者: Lars Køber.;Jens J Thune.;Jens C Nielsen.;Jens Haarbo.;Lars Videbæk.;Eva Korup.;Gunnar Jensen.;Per Hildebrandt.;Flemming H Steffensen.;Niels E Bruun.;Hans Eiskjær.;Axel Brandes.;Anna M Thøgersen.;Finn Gustafsson.;Kenneth Egstrup.;Regitze Videbæk.;Christian Hassager.;Jesper H Svendsen.;Dan E Høfsten.;Christian Torp-Pedersen.;Steen Pehrson.; .
来源: N Engl J Med. 2016年375卷13期1221-30页
The benefit of an implantable cardioverter-defibrillator (ICD) in patients with symptomatic systolic heart failure caused by coronary artery disease has been well documented. However, the evidence for a benefit of prophylactic ICDs in patients with systolic heart failure that is not due to coronary artery disease has been based primarily on subgroup analyses. The management of heart failure has improved since the landmark ICD trials, and many patients now receive cardiac resynchronization therapy (CRT).
|